strike a balance between the risks and benefits of use of PPIs for gastroesophageal reflux disease (GERD)

New guidelines will try to strike a balance between the risks and benefits of use of PPIs for gastroesophageal reflux disease (GERD).

PPIs are still the mainstay for treating patients with GERD...even though they've been under fire for some possible drawbacks.

PPIs likely increase the risk of Clostridium difficile and other GI infections...and there are questions about a higher risk of pneumonia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote